Elicio Therapeutics, Inc. (ELTX)
1.92
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.92
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Market Cap : 42.05M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 42.05M |
| October 01, 2026 | 42.05M |
| September 30, 2026 | 39.86M |
| September 29, 2026 | 40.30M |
| September 28, 2026 | 40.52M |
| September 25, 2026 | 40.30M |
| September 24, 2026 | 41.18M |
| September 23, 2026 | 40.96M |
| September 22, 2026 | 40.96M |
| September 21, 2026 | 41.83M |
| September 18, 2026 | 41.39M |
| September 17, 2026 | 40.85M |
| September 16, 2026 | 38.77M |
| September 15, 2026 | 43.58M |
| September 14, 2026 | 43.80M |
| September 11, 2026 | 44.90M |
| September 10, 2026 | 46.21M |
| September 09, 2026 | 47.75M |
| September 08, 2026 | 51.47M |
| September 04, 2026 | 52.78M |
| September 03, 2026 | 54.75M |
| September 02, 2026 | 55.85M |
| September 01, 2026 | 56.07M |
| August 31, 2026 | 59.13M |
| August 28, 2026 | 62.20M |
| Date | Value |
|---|---|
| August 27, 2026 | 65.70M |
| August 26, 2026 | 65.27M |
| August 25, 2026 | 65.92M |
| August 24, 2026 | 65.27M |
| August 21, 2026 | 66.58M |
| August 20, 2026 | 67.35M |
| August 19, 2026 | 68.55M |
| August 18, 2026 | 68.11M |
| August 17, 2026 | 66.14M |
| August 14, 2026 | 67.68M |
| August 13, 2026 | 68.99M |
| August 12, 2026 | 67.02M |
| August 11, 2026 | 66.36M |
| August 10, 2026 | 57.78M |
| August 07, 2026 | 59.46M |
| August 06, 2026 | 58.53M |
| August 05, 2026 | 59.46M |
| August 04, 2026 | 58.90M |
| August 03, 2026 | 53.31M |
| July 31, 2026 | 52.19M |
| July 30, 2026 | 54.24M |
| July 29, 2026 | 53.87M |
| July 28, 2026 | 54.99M |
| July 27, 2026 | 55.92M |
| July 24, 2026 | 55.92M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 356.27M |
| Amgen, Inc. | 217.88B |
| BioCryst Pharmaceuticals, Inc. | 2.086B |
| Imunon, Inc. | 5.972M |
| Curis, Inc. | 1.566M |
Market Cap Related Metrics
| Price to Book Value | 5.298 |
| Price | 1.92 |
| Earnings Yield | -110.1% |